January 28, 2021 10:35 (IST)
Follow us:
Moderna Moderna submits coronavirus vaccine data to obtain emergency use authorization
Washington/Sputnik: The pharmaceutical company Moderna said that it has submitted the results of its corona vaccine trials to the US Food and Drug Administration (FDA) in order to obtain emergency use authorization for the vaccine.
“Moderna’s data for the emergency use authorization request for mRNA-1273 has been submitted to the US FDA,” Moderna said via Twitter on Monday.
Moderna said that vaccine efficacy was 94.1 percent and reached 100 percent in severe COVID-19 cases. Moderna also said the vaccine is generally well tolerated and devoid of serious safety concerns.
At least three promising vaccine candidates are expected to receive emergency use authorization from US health authorities in coming weeks, according to media reports.
Latest Headlines
Canada: Indian consulate virtually observes 72nd Republic Day Wed, Jan 27 2021
Pakistan politics: Parties back PPP's no-confidence move against PM Imran Khan despite PML-N doubts Wed, Jan 27 2021
Guterres calls for ‘renewed approach to multilateralism’, through new peacebuilding appeal Wed, Jan 27 2021
UN rights experts urge Israel to respect international obligations Wed, Jan 27 2021
Security Council reforms must reflect 21st century realities, says UN Assembly President Wed, Jan 27 2021